ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,846, issued on July 14, was assigned to KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (Busan, South Korea).
"Xanthone compound having excellent anticancer effect" was invented by Hee Jae Shin (Busan, South Korea), Byeoung Kyu Choi (Chungcheongnam-do, South Korea) and Hwa Sun Lee (Busan, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel xanthone compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof that exhibits cytotoxicity against cancer cell lines and inhibits cancer cell growth, thereby exhibiting excellent preventive or therapeutic effects on various cancer cells."
Th...